Skip to main content
Equibles
ATR logo

ATR · Aptargroup, Inc. · Metrics

Track ATR — free

Use ATR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ATR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$125.77 +1.14 (+0.91%) At close · Oct 20
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$7.97B
Shares
63.58M
Volume · Oct 20 356.91K Avg daily vol (3M) 454.28K

ATR metrics

113 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$125.77
Market cap
$7.97B

Price action

20 metrics
Price change (1W)
+5.5%
Price change (30D)
+1.9%
Price change (3M)
-2.4%
Price change (6M)
-0.7%
Price change (YTD)
+3.1%
Price change (1Y)
-3.3%
Trailing year
Price change (5Y)
-1.9%
52-week high
$145.72
52-week low
$111.94
Change from 52-week high
-13.7%
Change from 52-week low
+12.4%
Annualized volatility
24.9%
Annualized volatility (3M)
18.1%
Beta
0.4
RSI (14D)
58.3
Price vs SMA 50
-0.6%
Price vs SMA 200
-0.8%
Avg volume (3M)
454,283
Relative volume
0.8
Average dollar volume
$58.19M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
63.58M

Valuation

12 metrics
P / E (TTM)
22.7
Trailing earnings · reciprocal yield 4.4%
PEG ratio
—
EV / revenue
2.3×
reciprocal yield 43.0%
EV / EBITDA
11.7×
reciprocal yield 8.6%
EV / EBIT
19.1×
reciprocal yield 5.2%
P / sales
2.0×
reciprocal yield 49.3%
P / book
3.0
reciprocal yield 33.0%
FCF yield
3.9%
TTM · current market cap
Buyback yield
4.6%
P / FCF
25.7
reciprocal yield 3.9%
P / operating cash flow
13.7
reciprocal yield 7.3%
Earnings yield
4.5%

Historical valuation

8 metrics
P / E historical average (3Y)
26.8×
reciprocal yield 3.7%
P / E historical average (5Y)
29.1×
reciprocal yield 3.4%
EV / revenue historical average (3Y)
2.8×
reciprocal yield 36.1%
EV / revenue historical average (5Y)
2.7×
reciprocal yield 36.6%
EV / EBIT historical average (3Y)
21.5×
reciprocal yield 4.6%
EV / EBIT historical average (5Y)
22.4×
reciprocal yield 4.5%
EV / EBITDA historical average (3Y)
14.2×
reciprocal yield 7.0%
EV / EBITDA historical average (5Y)
14.3×
reciprocal yield 7.0%

Dividends & buybacks

7 metrics
Dividend yield
1.5%
Trailing 12 months
Payout ratio
33.8%
Shareholder yield
6.1%
Dividend / share (TTM)
$1.92
Dividend growth YoY
+6.7%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-07-30

Earnings calendar

2 metrics
Next earnings
2026-10-30
Last earnings
2026-07-31

Profitability

9 metrics
Gross margin
—
Operating margin
12.1%
Trailing 12 months
Net margin
9.2%
Gross profit (TTM)
$906.01M
Operating profit (TTM)
$477.42M
Net income (TTM)
$362.52M
Trailing 12 months
Diluted EPS (TTM)
$5.53
FCF margin
7.9%
Effective tax rate
20.2%

Per share

11 metrics
Revenue per diluted share (TTM)
$60.21
Gross profit per diluted share (TTM)
$13.59
Operating profit per diluted share (TTM)
$7.30
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$5.54
Operating cash flow per diluted share (TTM)
$8.90
Free cash flow per diluted share (TTM)
$4.73
Capital expenditures per diluted share (TTM)
$4.18
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.62
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+6.3%
Year over year
Net income growth YoY
-21.6%
Revenue (TTM)
$3.93B
Trailing 12 months
EPS growth YoY
-18.6%
Shares change YoY
-4.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+4.4%
Revenue CAGR (5Y)
+5.2%
EPS CAGR (3Y)
+17.9%
EPS CAGR (5Y)
+12.9%
FCF CAGR (3Y)
+21.2%
FCF CAGR (5Y)
-1.6%

Quality

14 metrics
Return on equity
13.8%
Return on assets
7.1%
Debt / equity
0.5
Current ratio
1.6
EBITDA (TTM)
$784.59M
Free cash flow (TTM)
$310.39M
Quick ratio
1.1
Interest coverage
7.5
Net debt / EBITDA
1.5
Return on invested capital
10.0%
Trailing 12 months
Net cash
−$1.17B
Latest balance sheet
Cash & equivalents
$190.40M
Total assets
$5.13B
Total debt
$1.37B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$583.48M
Capital expenditures (TTM)
$273.09M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$40.80M
R&D / revenue
—
Stock compensation / revenue
1.0%

Ownership (13F)

9 metrics
13F filers
558
13F filer change QoQ
+11
Institutional ownership
96.5%
Conviction holders (share of 13F filers)
0.9%
Crowding (high-turnover and private-fund holders)
23.4%
Private-fund adviser ownership
22.2%
Active holders' share change QoQ
+2.9%
Holder tenure
18.2
Price vs estimated holder cost
-3.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
22.6%

Short interest

3 metrics
Short interest
3.3%
Latest settlement · 4.4 days to cover
Days to cover
4.4d
Short-squeeze score
61 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$3.61M
Insider-sentiment score
16 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 896622 CUSIP 038336103 13F (30d) 90 filings 75 filers Visit website Investor relations